J Pathol Transl Med.  2024 Nov;58(6):331-340. 10.4132/jptm.2024.10.12.

Fine needle aspiration cytology diagnoses of follicular thyroid carcinoma: results from a multicenter study in Asia

Affiliations
  • 1Department of Pathology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
  • 2Department of Diagnostic Pathology and Cytology, Kuma Hospital, Kobe, Japan
  • 3Department of Endocrine Surgery, Yamashita Thyroid Hospital, Fukuoka, Japan
  • 4Department of Pathology, Showa University Northern Yokohama Hospital, Yokohama, Japan
  • 5Department of Pathology, Ito Hospital, Tokyo, Japan
  • 6Department of Hospital Pathology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
  • 7Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
  • 8Department of Pathology, All India Institute of Medical Sciences, New Delhi, India
  • 9Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
  • 10Department of Pathology, Jiangyuan Hospital Affiliated to Jiangsu Institute of Nuclear Medicine, Wuxi, China
  • 11Department of Pathology, Shanghai Sixth People’s Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
  • 12Department of Pathology, Kameda Medical Center, Kamogawa, Japan
  • 13Department of Pathology and Thyroid Disease Center, Izumi City General Hospital, Izumi, Japan

Abstract

Background
This study was designed to compare diagnostic categories of thyroid fine needle aspiration cytology (FNAC) and incidence of thyroid tumors in the multi-institutional Asian series with a special focus on diagnostic category IV (suspicious for a follicular neoplasm) and follicular thyroid carcinomas (FTCs). Methods: Distribution of FNAC categories, incidence of thyroid tumors in resection specimens and cytologic diagnoses of surgically confirmed follicular adenomas (FAs) and FTCs were collected from 10 institutes from five Asian countries and were compared among countries and between FAs and FTCs. Results: The frequency of category IV diagnoses (3.0%) in preoperative FNAC were significantly lower compared to those in Western countries (10.1%). When comparing diagnostic categories among Asian countries, category IV was more frequent in Japan (4.6%) and India (7.9%) than in Taiwan (1.4%), Korea (1.4%), and China (3.6%). Similarly, incidence of FAs and FTCs in surgical resection specimens was significantly higher in Japan (10.9%) and India (10.1%) than in Taiwan (5.5%), Korea (3.0%), and China (2.5%). FTCs were more commonly diagnosed as category IV in Japan (77.5%) than in Korea (33.3%) and China (35.0%). Nuclear pleomorphism, nuclear crowding, microfollicular pattern, and dyshesive cell pattern were more common in FTCs compared with FAs. Conclusions: Our study highlighted the difference in FNAC diagnostic categories of FTCs among Asian countries, which is likely related to different reporting systems and thyroid cancer incidence. Cytologic features such as nuclear pleomorphism, nuclear crowding, microfollicular pattern, and dyshesive cell pattern were found to be useful in diagnosing FTCs more effectively.

Keyword

Thyroid; Biopsy, fine-needle; Adenoma, follicular; Adenocarcinoma, follicular; Follicular neoplasm; Thyroid neoplasms

Figure

  • Fig. 1. The distribution of fine needle aspiration cytology diagnostic categories and surgical diagnoses of thyroidectomy specimens among Asian countries. (A) The frequency of diagnostic category IV (suspicious for a follicular neoplasm [SFN]) is higher in Japan and India than in other countries. The frequency of diagnostic category III (atypia of undetermined significance [AUS]), V (suspicious for malignancy [SM]), and VI (malignant) is higher in Korea and China. (B) Surgical diagnoses of follicular-patterned neoplasm including follicular adenoma (FA), Hürthle cell adenoma (HCA), Hürthle cell carcinoma (HCC), follicular thyroid carcinoma (FTC), noninvasive follicular thyroid neoplasm with papillarylike nuclear features (NIFTP) and invasive encapsulated follicular variant papillary thyroid carcinoma (IEFVPTC), are significantly more frequent in Japan and India than in other Asian countries. In Korea and China, papillary thyroid carcinomas (PTCs), including papillary microcarcinomas (PMCs), are more prevalent than in other countries.

  • Fig. 2. Distribution of preoperative fine needle aspiration cytology diagnostic categories of follicular adenomas and follicular thyroid carcinomas. (A) Follicular adenomas are more frequently diagnosed as diagnostic category III (atypia of undetermined significance [AUS]) in Korea than in Japan. (B) Follicular thyroid carcinomas are more commonly diagnosed as category IV (suspicious for a follicular neoplasm [SFN]) in Japan and India than in Korea and China. On the other hand, they were more frequently diagnosed as category III (AUS) in Korea than in Japan. SM, suspicious for malignancy.

  • Fig. 3. Cytologic features of follicular thyroid carcinomas (FTCs). Predominant microfollicular pattern (A) and extensive dyshesive cells (B) are more commonly observed in FTCs. (C, D) High power view of microfollicles shows marked nuclear crowding and nuclear pleomorphism, which are more frequent in FTCs. Nuclear enlargement (E) and hyperchromatism (F) are more common in angioinvasive FTCs and widely invasive FTCs compared to minimally invasive FTCs.


Reference

References

1. Baloch ZW, Livolsi VA. Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol. 2002; 117:143–50.
2. Zacks JF, de las Morenas A, Beazley RM, O’Brien MJ. Fine-needle aspiration cytology diagnosis of colloid nodule versus follicular variant of papillary carcinoma of the thyroid. Diagn Cytopathol. 1998; 18:87–90.
Article
3. Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2017; 27:1341–6.
Article
4. Deveci MS, Deveci G, LiVolsi VA, Baloch ZW. Fine-needle aspiration of follicular lesions of the thyroid: diagnosis and follow-up. Cytojournal. 2006; 3:9.
5. Wu HH, Rose C, Elsheikh TM. The Bethesda system for reporting thyroid cytopathology: an experience of 1,382 cases in a community practice setting with the implication for risk of neoplasm and risk of malignancy. Diagn Cytopathol. 2012; 40:399–403.
Article
6. Yang J, Schnadig V, Logrono R, Wasserman PG. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer. 2007; 111:306–15.
Article
7. Bommanahalli B, Bhat R, Rupanarayan R. A cell pattern approach to interpretation of fine needle aspiration cytology of thyroid lesions: a cyto-histomorphological study. J Cytol. 2010; 27:127–32.
Article
8. Bongiovanni M, Sykiotis GP, La Rosa S, et al. Macrofollicular variant of follicular thyroid carcinoma: a rare underappreciated pitfall in the diagnosis of thyroid carcinoma. Thyroid. 2020; 30:72–80.
Article
9. Na HY, Moon JH, Choi JY, et al. Preoperative diagnostic categories of fine needle aspiration cytology for histologically proven thyroid follicular adenoma and carcinoma, and Hurthle cell adenoma and carcinoma: analysis of cause of under- or misdiagnoses. PLoS One. 2020; 15:e0241597.
Article
10. Vuong HG, Ngo HT, Bychkov A, et al. Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries: a systematic review and meta-analysis. Cancer Cytopathol. 2019; 128:238–49.
Article
11. Kim M, Park HJ, Min HS, et al. The use of the Bethesda System for Reporting Thyroid Cytopathology in Korea: a nationwide multicenter survey by the Korean Society of Endocrine Pathologists. J Pathol Transl Med. 2017; 51:410–7.
Article
12. Bychkov A, Kakudo K, Hong S. Current practices of thyroid fine-needle aspiration in Asia: a missing voice. J Pathol Transl Med. 2017; 51:517–20.
Article
13. Kakudo K, Higuchi M, Hirokawa M, Satoh S, Jung CK, Bychkov A. Thyroid FNA cytology in Asian practice-Active surveillance for indeterminate thyroid nodules reduces overtreatment of thyroid carcinomas. Cytopathology. 2017; 28:455–66.
Article
14. Kakudo K, Jung CK, Liu Z, et al. The Asian Thyroid Working Group, from 2017 to 2023. J Pathol Transl Med. 2023; 57:289–304.
Article
15. Jung CK, Hong S, Bychkov A, Kakudo K. The use of fine-needle aspiration (FNA) cytology in patients with thyroid nodules in Asia: a brief overview of studies from the Working Group of Asian Thyroid FNA Cytology. J Pathol Transl Med. 2017; 51:571–8.
Article
16. Japan Thyroid Association. Guidelines for clinical practice for the management of thyroid nodules in Japan 2013. Tokyo: Nankodo Co., Ltd;2013.
17. Kini SR. Thyroid cytopathology: an atlas and text. Philadelphia: Lippincott Williams and Wilkins;2008.
18. Lloyd R, Osamura R, Kloppel G, Rosai J. WHO classification of tumours of endocrine organs. Lyon: IARC Press;2017. 4th.
19. Ha EJ, Na DG, Baek JH. Korean Thyroid Imaging Reporting and Data System: current status, challenges, and future perspectives. Korean J Radiol. 2021; 22:1569–78.
Article
20. Miranda-Filho A, Lortet-Tieulent J, Bray F, et al. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 2021; 9:225–34.
Article
21. Pereira M, Williams VL, Hallanger Johnson J, Valderrabano P. Thyroid cancer incidence trends in the United States: association with changes in professional guideline recommendations. Thyroid. 2020; 30:1132–40.
Article
22. Rana C, Vuong HG, Nguyen TQ, et al. The incidence of noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a meta-analysis assessing worldwide impact of the reclassification. Thyroid. 2021; 31:1502–13.
Article
23. Bychkov A, Jung CK, Liu Z, Kakudo K. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian practice: perspectives for surgical pathology and cytopathology. Endocr Pathol. 2018; 29:276–88.
Article
24. Bychkov A, Hirokawa M, Jung CK, et al. Low rate of noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian Practice. Thyroid. 2017; 27:983–4.
Article
25. Zhu Y, Li Y, Jung CK, et al. Histopathologic assessment of capsular invasion in follicular thyroid neoplasms: an observer variation study. Endocr Pathol. 2020; 31:132–40.
Article
26. Bhattacharyya N. Survival and prognosis in Hurthle cell carcinoma of the thyroid gland. Arch Otolaryngol Head Neck Surg. 2003; 129:207–10.
Article
27. Hundahl SA, Cady B, Cunningham MP, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study. Cancer. 2000; 89:202–17.
Article
28. Agarwal S, Bychkov A, Jung CK, et al. The prevalence and surgical outcomes of Hurthle cell lesions in FNAs of the thyroid: a multi-institutional study in 6 Asian countries. Cancer Cytopathol. 2019; 127:181–91.
29. Thompson LD, Poller DN, Kakudo K, Burchette R, Nikiforov YE, Seethala RR. An international interobserver variability reporting of the nuclear scoring criteria to diagnose noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a validation study. Endocr Pathol. 2018; 29:242–9.
Article
30. Liu Z, Bychkov A, Jung CK, et al. Interobserver and intraobserver variation in the morphological evaluation of noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian practice. Pathol Int. 2019; 69:202–10.
Article
31. Ahn HS, Kim HJ, Kim KH, et al. Thyroid cancer screening in South Korea increases detection of papillary cancers with no impact on other subtypes or thyroid cancer mortality. Thyroid. 2016; 26:1535–40.
Article
32. Lee JH, Shin SW. Overdiagnosis and screening for thyroid cancer in Korea. Lancet. 2014; 384:1848.
Article
33. Kakudo K, Kameyama K, Miyauchi A, Nakamura H. Introducing the reporting system for thyroid fine-needle aspiration cytology according to the new guidelines of the Japan Thyroid Association. Endocr J. 2014; 61:539–52.
Article
34. Kameyama K, Sasaki E, Sugino K, Ito K. The Japanese Thyroid Association Reporting System of thyroid aspiration cytology and experience from a high-volume center, especially in indeterminate category. J Basic Clin Med. 2015; 4:70–4.
35. Satoh S, Yamashita H, Kakudo K. Thyroid Cytology: the Japanese system and experience at Yamashita Thyroid Hospital. J Pathol Transl Med. 2017; 51:548–54.
Article
36. Boon ME, Lowhagen T, Willems JS. Planimetric studies on fine needle aspirates from follicular adenoma and follicular carcinoma of the thyroid. Acta Cytol. 1980; 24:145–8.
37. Crissman JD, Drozdowicz S, Johnson C, Kini SR. Fine needle aspiration diagnosis of hyperplastic and neoplastic follicular nodules of the thyroid: a morphometric study. Anal Quant Cytol Histol. 1991; 13:321–8.
38. Luck JB, Mumaw VR, Frable WJ. Fine needle aspiration biopsy of the thyroid. Differential diagnosis by videoplan image analysis. Acta Cytol. 1982; 26:793–6.
39. Wright RG, Castles H, Mortimer RH. Morphometric analysis of thyroid cell aspirates. J Clin Pathol. 1987; 40:443–5.
Article
40. Gupta S, Savala R, Gupta N, Dey P. Fractal dimension and chromatin textural analysis to differentiate follicular carcinoma and adenoma on fine needle aspiration cytology. Cytopathology. 2020; 31:491–3.
Article
41. Savala R, Dey P, Gupta N. Artificial neural network model to distinguish follicular adenoma from follicular carcinoma on fine needle aspiration of thyroid. Diagn Cytopathol. 2018; 46:244–9.
Article
42. Han K, Ha HJ, Kong JS, et al. Cytological features that differentiate follicular neoplasm from mimicking lesions. J Pathol Transl Med. 2018; 52:110–20.
Article
43. Cervino JM, Paseyro P, Grosso OF, Maggiolo J. The cytological examination of the thyroid gland and its anatomo-clinical correlations. An Fac Med Univ Repub Montev Urug. 1962; 47:128–43.
Full Text Links
  • JPTM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr